These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18204435)

  • 1. RT in situ PCR detection of MART-1 and TRP-2 mRNA in formalin-fixed, paraffin-embedded tissues of melanoma and nevi.
    Itakura E; Huang RR; Wen DR; Paul E; Wünsch PH; Cochran AJ
    Mod Pathol; 2008 Mar; 21(3):326-33. PubMed ID: 18204435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution.
    Hofbauer GF; Kamarashev J; Geertsen R; Böni R; Dummer R
    Melanoma Res; 1998 Aug; 8(4):337-43. PubMed ID: 9764809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue.
    Koh SS; Opel ML; Wei JP; Yau K; Shah R; Gorre ME; Whitman E; Shitabata PK; Tao Y; Cochran AJ; Abrishami P; Binder SW
    Mod Pathol; 2009 Apr; 22(4):538-46. PubMed ID: 19270649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Stealth" melanoma cells in histology-negative sentinel lymph nodes.
    Itakura E; Huang RR; Wen DR; Cochran AJ
    Am J Surg Pathol; 2011 Nov; 35(11):1657-65. PubMed ID: 21997686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards quantitative mRNA analysis in paraffin-embedded tissues using real-time reverse transcriptase-polymerase chain reaction: a methodological study on lymph nodes from melanoma patients.
    Abrahamsen HN; Steiniche T; Nexo E; Hamilton-Dutoit SJ; Sorensen BS
    J Mol Diagn; 2003 Feb; 5(1):34-41. PubMed ID: 12552078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions-a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions.
    Mudhar HS; Milman T; Stevenson S; Watson M; Kim J; Magan T; Salvi SM; Harley U; Lally SE; Shields CL
    Hum Pathol; 2023 Apr; 134():1-18. PubMed ID: 36804828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions.
    de Vries TJ; Fourkour A; Wobbes T; Verkroost G; Ruiter DJ; van Muijen GN
    Cancer Res; 1997 Aug; 57(15):3223-9. PubMed ID: 9242453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAGE-3 immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution.
    Hofbauer GF; Schaefer C; Noppen C; Böni R; Kamarashev J; Nestle FO; Spagnoli GC; Dummer R
    Am J Pathol; 1997 Dec; 151(6):1549-53. PubMed ID: 9403705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes.
    Goto Y; Ferrone S; Arigami T; Kitago M; Tanemura A; Sunami E; Nguyen SL; Turner RR; Morton DL; Hoon DS
    Clin Cancer Res; 2008 Jun; 14(11):3401-7. PubMed ID: 18519770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative relationships between pigment-related mRNA and biochemical melanoma markers in melanoma cell lines.
    Johansson M; Takasaki A; Lenner L; Arstrand K; Kågedal B
    Melanoma Res; 2002 Jun; 12(3):193-200. PubMed ID: 12140375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cells.
    Schrader AJ; Probst-Kepper M; Grosse J; Kunter U; Schenk F; Franzke A; Atzpodien J; Buer J
    Melanoma Res; 2000 Aug; 10(4):355-62. PubMed ID: 10985670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RT-PCR detection of tyrosinase, gp100, MART1/Melan-A, and TRP-2 gene transcripts in peripheral blood of melanoma patients.
    Samija M; Juretić A; Solarić M; Samija I; Bingulac-Popović J; Grahovac B; Stanec M; Oresić V
    Croat Med J; 2001 Aug; 42(4):478-83. PubMed ID: 11471202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of tyrosinase mRNA in formalin-fixed, paraffin-embedded archival sections of melanoma, using the reverse transcriptase in situ polymerase chain reaction.
    Guo J; Cheng L; Wen DR; Huang RR; Cochran AJ
    Diagn Mol Pathol; 1998 Feb; 7(1):10-5. PubMed ID: 9646029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosinase immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution.
    Hofbauer GF; Kamarashev J; Geertsen R; Böni R; Dummer R
    J Cutan Pathol; 1998 Apr; 25(4):204-9. PubMed ID: 9609139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a multiple-marker polymerase chain reaction assay for detection of metastatic melanoma in lymph node aspirates of dogs.
    Catchpole B; Gould SM; Kellett-Gregory LM; Dobson JM
    Am J Vet Res; 2003 May; 64(5):544-9. PubMed ID: 12755292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of insulin-like growth factor I (IGF-I) in nevi and melanomas.
    Fleming MG; Howe SF; Graf LH
    Am J Dermatopathol; 1994 Aug; 16(4):383-91. PubMed ID: 7978067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma-associated antigens as messenger RNA detection markers for melanoma.
    Sarantou T; Chi DD; Garrison DA; Conrad AJ; Schmid P; Morton DL; Hoon DS
    Cancer Res; 1997 Apr; 57(7):1371-6. PubMed ID: 9102226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative assessment of the expression of melanoma-associated antigens by non-competitive reverse transcription polymerase chain reaction.
    Ringhoffer M; Schmitt M; Karbach J; Jäger E; Oesch F; Arand M
    Int J Oncol; 2001 Nov; 19(5):983-9. PubMed ID: 11604998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical studies of conjunctival nevi and melanomas.
    Jakobiec FA; Bhat P; Colby KA
    Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemistry for PRAME in Dermatopathology.
    Lezcano C; Jungbluth AA; Busam KJ
    Am J Dermatopathol; 2023 Nov; 45(11):733-747. PubMed ID: 37856737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.